메뉴 건너뛰기
JAMA - Journal of the American Medical Association
Volumn 320, Issue 10, 2018, Pages 1031-1032
Diagnosis and treatment of clostridium difficile infection
Author keywords

[No Author keywords available]
Indexed keywords

BEZLOTOXUMAB; FIDAXOMICIN; GLUTAMATE DEHYDROGENASE; METRONIDAZOLE; PLACEBO; RIDINILAZOLE; VANCOMYCIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;
EID: 85052922664     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.12194     Document Type: Short Survey
Times cited : (36)
References (8)
  • 1
    • 85026636209 scopus 로고    scopus 로고
    • Increasing incidence of multiply recurrent Clostridium difficile infection in the United States
    • Ma GK, Brensinger CM, Wu Q, Lewis JD. Increasing incidence of multiply recurrent Clostridium difficile infection in the United States. Ann Intern Med. 2017;167(3):152-158. doi:10.7326 /M16-2733
    • (2017) Ann Intern Med , vol.167 , Issue.3 , pp. 152-158
    • Ma, G.K.1    Brensinger, C.M.2    Wu, Q.3    Lewis, J.D.4
  • 2
    • 84921767408 scopus 로고    scopus 로고
    • Diagnosis and treatment of Clostridium difficile in adults
    • Bagdasarian N, Rao K, Malani PN. Diagnosis and treatment of Clostridium difficile in adults. JAMA. 2015;313(4):398-408. doi:10.1001/jama.2014.17103
    • (2015) JAMA , vol.313 , Issue.4 , pp. 398-408
    • Bagdasarian, N.1    Rao, K.2    Malani, P.N.3
  • 3
    • 85044201854 scopus 로고    scopus 로고
    • Clinical practice guidelines for Clostridium difficile infection in adults and children
    • McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children. Clin Infect Dis. 2018;66(7):987-994. doi:10.1093/cid/ciy149
    • (2018) Clin Infect Dis , vol.66 , Issue.7 , pp. 987-994
    • McDonald, L.C.1    Gerding, D.N.2    Johnson, S.3
  • 4
    • 79551527297 scopus 로고    scopus 로고
    • Fidaxomicin versus vancomycin for Clostridium difficile infection
    • Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422-431. doi:10.1056/NEJMoa0910812
    • (2011) N Engl J Med , vol.364 , Issue.5 , pp. 422-431
    • Louie, T.J.1    Miller, M.A.2    Mullane, K.M.3
  • 5
    • 84863676557 scopus 로고    scopus 로고
    • Treatment of first recurrence of Clostridium difficile infection
    • Cornely OA, Miller MA, Louie TJ, et al. Treatment of first recurrence of Clostridium difficile infection. Clin Infect Dis. 2012;55(suppl 2):S154-S161. doi:10 .1093/cid/cis462
    • (2012) Clin Infect Dis , vol.55 , pp. S154-S161
    • Cornely, O.A.1    Miller, M.A.2    Louie, T.J.3
  • 6
    • 85037042631 scopus 로고    scopus 로고
    • Effect of oral capsule- Vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection
    • Kao D, Roach B, Silva M, et al. Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent Clostridium difficile infection. JAMA. 2017;318(20):1985-1993. doi:10 .1001/jama.2017.17077
    • (2017) JAMA , vol.318 , Issue.20 , pp. 1985-1993
    • Kao, D.1    Roach, B.2    Silva, M.3
  • 7
    • 85007613626 scopus 로고    scopus 로고
    • Repeat Clostridium difficile testing
    • Gupta A, Khanna S. Repeat Clostridium difficile testing. JAMA. 2016;316(22):2422-2423. doi:10 .1001/jama.2016.17173
    • (2016) JAMA , vol.316 , Issue.22 , pp. 2422-2423
    • Gupta, A.1    Khanna, S.2
  • 8
    • 85027884550 scopus 로고    scopus 로고
    • Bezlotoxumab (Zinplava) for prevention of recurrent Clostridium difficile infection
    • Bezlotoxumab (Zinplava) for prevention of recurrent Clostridium difficile infection. JAMA. 2017; 318(7):659-660. doi:10.1001/jama.2017.10092
    • (2017) JAMA , vol.318 , Issue.7 , pp. 659-660

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.